2018 annual financial data
Propanc Biopharma, Inc. 2018 Operating margin
Propanc Biopharma, Inc. 2018 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -3,960,000 USD and net income was -7,039,000 USD.
Operating cash flow was -2,177,645 USD.
Get free Propanc Biopharma, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,960,000 USD
- Net income
- -7,039,000 USD
- Operating cash flow
- -2,177,645 USD